Healthcare

● The slide erased about $24 billion of market value, according to reports.

NewAmsterdam Pharma Company (NASDAQ:NAMS) shares were trading near their 52-week low at USD 21.50 on October 21, 2026, down 0.02%. The late-stage biopharmaceutical company announced a positive CHMP opinion for obicetrapib in July, reported a second quarter 2026 net loss of $64.1 million in …

PTC Therapeutics (NASDAQ:PTCT) shares were trading near their 52-week low at USD 62.78 on October 21, 2026, down 0.22%. The rare disease drugmaker filed its second quarter 2026 report on July 30, reporting a $50.0 million milestone from Novartis for starting a Phase 3 …

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) shares were trading near their 52-week low at USD 41.21 on October 21, 2026, down 0.05%. The biopharmaceutical company announced on October 19 that it will report third quarter 2026 results on October 29 and host a conference call the …

Xenon Pharmaceuticals (NASDAQ:XENE) shares were trading near their 52-week low at USD 36.04 on October 21, 2026, down 0.63%. The neuroscience-focused biopharmaceutical company raised $707.6 million in a public offering in March and reported second quarter 2026 results in a Form 10-Q filed August …

Agilent Technologies (NYSE:A) shares were trading near their 52-week high at USD 177.53 on October 21, 2026, up 2.61%. The life sciences and diagnostics group closed a $950 million pathology acquisition in late June, issued a bond a day later, and reported fiscal third …

American Well Corporation (NYSE:AMWL) shares were trading near their 52-week high at USD 13.89 on October 21, 2026, up 5.23%. The digital care platform company finalized contingent consideration from its earlier sale of the APC business in the first half, reported a narrower second …